| Literature DB >> 26574623 |
Willem A Velema1, Mickel J Hansen1, Michael M Lerch1, Arnold J M Driessen2, Wiktor Szymanski1,3, Ben L Feringa1.
Abstract
Photopharmacology aims to locally treat diseases and study biological processes with photoresponsive drugs. Herein, easy access to photoswitchable drugs is crucial, which is supported by simple and robust drug modifications. We investigated the possibility of creating drugs that can undergo remote activation and deactivation with light, by conjugating molecular photoswitches to the exterior of an existing drug in a single chemical step. This facile strategy allows the convenient introduction of various photochromic systems into a drug molecule, rendering it photoresponsive. To demonstrate the feasibility of this approach, two photoswitch-modified ciprofloxacin antibiotics were synthesized. Remarkably, for one of them a 50-fold increase in activity compared to the original ciprofloxacin was observed. Their antimicrobial activity could be spatiotemporally controlled with light, which was exemplified by bacterial patterning studies.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26574623 DOI: 10.1021/acs.bioconjchem.5b00591
Source DB: PubMed Journal: Bioconjug Chem ISSN: 1043-1802 Impact factor: 6.069